ENvue Medical (FEED) Non-Current Deffered Revenue (2020 - 2024)
ENvue Medical's (FEED) quarterly Non-Current Deffered Revenue came in at $1000.0 in Q2 2024, down 98.81% year-on-year from $84000.0 in Q3 2023, and down 75.0% on a QoQ basis from $4000.0 in Q1 2024.
ENvue Medical (FEED) Non-Current Deffered Revenue (2020 - 2024) Analysis & Trends
ENvue Medical (FEED) has 5 years of Non-Current Deffered Revenue data on file, last reported at $1000.0 in Q2 2024.
- On a quarterly basis, Non-Current Deffered Revenue fell 98.81% year-over-year to $1000.0 in Q2 2024; TTM through Jun 2024 was $1000.0, a 98.81% decrease from a year earlier, with the FY2023 full-year figure at $15000.0, down 85.98% from the prior year.
- Non-Current Deffered Revenue for Q2 2024 stood at $1000.0, down from $4000.0 in the prior quarter.
- Over the last five years, Non-Current Deffered Revenue for FEED reached as high as $271000.0 in Q3 2021 and fell as low as $1000.0 in Q2 2024.
- Historically, Non-Current Deffered Revenue has averaged $129352.9 across 5 years, with a median of $130000.0 in 2022.
- Across the five-year window, Non-Current Deffered Revenue increased 26.05% in 2021 and slumped 98.81% in 2024, its largest moves.
- Year by year, Non-Current Deffered Revenue stood at $199000.0 in 2020, then decreased by 23.12% to $153000.0 in 2021, then tumbled by 30.07% to $107000.0 in 2022, then slumped by 85.98% to $15000.0 in 2023, then plunged by 93.33% to $1000.0 in 2024.
- Per Business Quant data, the three most recent Non-Current Deffered Revenue figures were $1000.0 in Q2 2024, $4000.0 in Q1 2024, and $15000.0 in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.86 Bn | 175.56 Bn | 6.27 Bn | - |
| 2 | Stryker | 128.95 Bn | 126.07 Bn | 3.81 Bn | - |
| 3 | Medtronic | 108.31 Bn | 99.09 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 68.46 Bn | 67.01 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 48.25 Bn | 44.58 Bn | 1.29 Bn | - |
| 6 | Dexcom | 28.35 Bn | 27.23 Bn | 750.30 Mn | - |
| 7 | GE HealthCare Technologies | 28.05 Bn | 25.76 Bn | 1.98 Bn | - |
| 8 | Smith & Nephew | 26.96 Bn | 26.38 Bn | - | - |
| 9 | Koninklijke Philips | 24.06 Bn | 20.93 Bn | 2.07 Bn | 512.79 Mn |
| 10 | ENvue Medical | 1.20 Mn | -1.06 Mn | -55,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | 1,000.00 |
| Mar 31, 2024 | 4,000.00 |
| Dec 31, 2023 | 15,000.00 |
| Sep 30, 2023 | 73,000.00 |
| Jun 30, 2023 | 84,000.00 |
| Mar 31, 2023 | 96,000.00 |
| Dec 31, 2022 | 107,000.00 |
| Sep 30, 2022 | 119,000.00 |
| Jun 30, 2022 | 130,000.00 |
| Mar 31, 2022 | 142,000.00 |
| Dec 31, 2021 | 153,000.00 |
| Sep 30, 2021 | 271,000.00 |
| Jun 30, 2021 | 176,000.00 |
| Mar 31, 2021 | 188,000.00 |
| Dec 31, 2020 | 199,000.00 |
| Sep 30, 2020 | 215,000.00 |
| Jun 30, 2020 | 226,000.00 |